Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rothenfusser

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|December 4, 2023
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiologyHanna F Nowotny, Thomas Marchant Seiter, Jing Ju, et al.
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
Hepatology (Baltimore, Md.)|August 19, 2014
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virusFranziska S Hoffmann, Andreas Schmidt, Meike Dittmann Chevillotte, et al.
Cancer Research|October 4, 2015
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progressionDavid Anz, Moritz Rapp, Stephan Eiber, et al.
Leukemia|November 20, 2019
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockadeMichael Ruzicka, Lars M Koenig, Simone Formisano, et al.
International Archives of Allergy and Immunology|February 13, 2008
Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndromeMehdi Yeganeh, Philipp Henneke, Nima Rezaei, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Science Immunology|July 17, 2021
OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosisDaniel F R Boehmer, Simone Formisano, Carina C de Oliveira Mann, et al.
Molecular Cancer Therapeutics|June 25, 2026
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma modelCharlotte Marx, Julia Teppert, Laura Marisch, et al.
Nature Communications|February 24, 2024
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infectionAntonio Santos-Peral, Fabian Luppa, Sebastian Goresch, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|December 4, 2023
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiologyHanna F Nowotny, Thomas Marchant Seiter, Jing Ju, et al.
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
Hepatology (Baltimore, Md.)|August 19, 2014
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virusFranziska S Hoffmann, Andreas Schmidt, Meike Dittmann Chevillotte, et al.
Cancer Research|October 4, 2015
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progressionDavid Anz, Moritz Rapp, Stephan Eiber, et al.
Leukemia|November 20, 2019
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockadeMichael Ruzicka, Lars M Koenig, Simone Formisano, et al.
International Archives of Allergy and Immunology|February 13, 2008
Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndromeMehdi Yeganeh, Philipp Henneke, Nima Rezaei, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Science Immunology|July 17, 2021
OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosisDaniel F R Boehmer, Simone Formisano, Carina C de Oliveira Mann, et al.
Molecular Cancer Therapeutics|June 25, 2026
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma modelCharlotte Marx, Julia Teppert, Laura Marisch, et al.
Nature Communications|February 24, 2024
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infectionAntonio Santos-Peral, Fabian Luppa, Sebastian Goresch, et al.
Pageof 10